Bipolar I Disorder – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Bipolar I disorder is a persistent mental health condition characterized by alternating phases of heightened mood, known as mania, and low mood, known as depression. Mania is described as a distinct period of excessively elevated, expansive, or irritable mood, accompanied by increased activity or energy, lasting at least a week and occurring most days, often requiring hospitalization if shorter. This disorder affects approximately 1 in 100 adults, posing a significant public health concern. It typically manifests with a mix of manic and depressive symptoms, leading to severe disruptions in mood lasting weeks or months, impacting various aspects of daily life and functioning. While the monoaminergic neurotransmitter systems—such as serotonin, norepinephrine, and dopamine—have been central to theories and research on mood disorder origins, no single neurotransmitter system dysfunction has been conclusively identified in bipolar disorder despite evidence suggesting their involveme...